ANGO - AngioDynamics, Inc.
NASDAQ
->
Healthcare
->
Medical Instruments & Supplies
Latham,
United States
Type: Equity
ANGO price evolution
ANGO
| (in millions $) | 1 Oct 2024 | 1 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $76.06 | $78.45 | $60.9 | |
| Short term investments | ||||
| Net receivables | $39.56 | $43.61 | $49.48 | $51.6 |
| Inventory | $64.7 | $60.62 | $58.07 | $64.25 |
| Total current assets | $172.59 | $193.25 | $196.91 | $185.47 |
| Long term investments | ||||
| Property, plant & equipment | $39.69 | $35.67 | $37.04 | $42.56 |
| Goodwill & intangible assets | $77.38 | $81.57 | $263.12 | |
| Total noncurrent assets | $124.42 | $127.94 | $314.15 | |
| Total investments | ||||
| Total assets | $293.63 | $317.67 | $324.84 | $499.62 |
| Current liabilities | ||||
| Accounts payable | $31.27 | $37.75 | $35.15 | $37.65 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $76.7 | $91.16 | $85.87 | $78.04 |
| Long term debt | ||||
| Total noncurrent liabilities | $20.93 | $20.27 | $20.36 | |
| Total debt | ||||
| Total liabilities | $97.05 | $112.08 | $106.14 | $98.4 |
| Shareholders' equity | ||||
| Retained earnings | -$408 | -$395.2 | -$381.75 | -$194.02 |
| Other shareholder equity | -$3.27 | $205.59 | -$2.81 | -$4.71 |
| Total shareholder equity | $205.59 | $218.7 | $401.23 | |
| (in millions $) | 1 Jul 2024 | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $76.06 | $44.62 | $28.82 | $48.16 |
| Short term investments | ||||
| Net receivables | $43.61 | $52.83 | $52.3 | $35.41 |
| Inventory | $60.62 | $55.33 | $51.39 | $48.61 |
| Total current assets | $193.25 | $163.54 | $143.34 | $140.88 |
| Long term investments | ||||
| Property, plant & equipment | $35.67 | $44.38 | $45.01 | $37.07 |
| Goodwill & intangible assets | $77.38 | $270.38 | $353.44 | $370.29 |
| Total noncurrent assets | $124.42 | $369.1 | $409.41 | $420.56 |
| Total investments | ||||
| Total assets | $317.67 | $532.64 | $552.75 | $561.44 |
| Current liabilities | ||||
| Accounts payable | $37.75 | $40.45 | $28.05 | $19.63 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $91.16 | $83.83 | $74.32 | $57.58 |
| Long term debt | $49.82 | $25 | $20 | |
| Total noncurrent liabilities | $20.93 | $70.52 | $53.94 | $64.4 |
| Total debt | $49.82 | $25 | $20 | |
| Total liabilities | $112.08 | $154.34 | $128.26 | $121.98 |
| Shareholders' equity | ||||
| Retained earnings | -$395.2 | -$210.85 | -$158.41 | -$131.87 |
| Other shareholder equity | $205.59 | $378.3 | $1.36 | $3.15 |
| Total shareholder equity | $205.59 | $378.3 | $424.49 | $439.46 |
| (in millions $) | 1 May 2025 | 1 Oct 2024 | 1 Jul 2024 | 1 May 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $67.49 | $70.98 | ||
| Cost of revenue | ||||
| Gross Profit | $36.72 | $38.52 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $45.51 | $44.55 | ||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $0.13 | -$0.69 | ||
| Interest expense | $0.61 | $0.57 | ||
| Net income | ||||
| Net income | -$12.8 | -$13.45 | ||
| Income (for common shares) | ||||
| (in millions $) | 1 Jul 2024 | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $303.91 | $291.01 | ||
| Cost of revenue | $134.22 | |||
| Gross Profit | $154.7 | $156.79 | ||
| Operating activities | ||||
| Research & development | $36.39 | |||
| Selling, general & administrative | $117.22 | |||
| Total operating expenses | $188.97 | $191.89 | ||
| Operating income | -$35.1 | |||
| Income from continuing operations | ||||
| EBIT | -$35.19 | |||
| Income tax expense | -$7.29 | -$4.5 | ||
| Interest expense | $1.61 | $0.86 | ||
| Net income | ||||
| Net income | -$184.35 | -$31.55 | ||
| Income (for common shares) | -$31.55 | |||
| (in millions $) | 1 Oct 2024 | 1 Jul 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$187.74 | -$29.05 | ||
| Operating activities | ||||
| Depreciation | $8.01 | $7.17 | ||
| Business acquisitions & disposals | ||||
| Stock-based compensation | $2.61 | $1.88 | ||
| Total cash flows from operations | -$12.53 | $5.27 | ||
| Investing activities | ||||
| Capital expenditures | $32.65 | -$1.79 | ||
| Investments | ||||
| Total cash flows from investing | -$2.4 | $123.72 | $29.4 | -$1.79 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.69 | -$0.35 | ||
| Net borrowings | ||||
| Total cash flows from financing | -$0.51 | -$64.25 | $0.69 | -$0.35 |
| Effect of exchange rate | $0.12 | $0.13 | -$0.02 | $0.19 |
| Change in cash and equivalents | -$21.05 | $31.44 | $17.55 | $3.31 |
| (in millions $) | 1 Jul 2024 | 1 Jul 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Net income | -$26.55 | -$31.55 | ||
| Operating activities | ||||
| Depreciation | $31.79 | $28.37 | ||
| Business acquisitions & disposals | -$3.6 | |||
| Stock-based compensation | $10.69 | $8.63 | ||
| Total cash flows from operations | -$7.19 | $24.09 | ||
| Investing activities | ||||
| Capital expenditures | -$15.71 | -$13.71 | ||
| Investments | ||||
| Total cash flows from investing | $123.72 | -$9.75 | -$19.31 | -$13.71 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $2.68 | $3.01 | ||
| Net borrowings | $5 | -$20 | ||
| Total cash flows from financing | -$64.25 | $25.42 | $7.68 | -$16.99 |
| Effect of exchange rate | $0.13 | $0.04 | -$0.52 | $0.33 |
| Change in cash and equivalents | $31.44 | $15.79 | -$19.34 | -$6.27 |
News
Fundamentals
| Market cap | $548.23M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 41.00M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.55 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.25 |
| Quick ratio | 1.41 |